Skip to content

The effect of treatment based on acceptance and commitment on tolerance of failure and fear of disease worsening in cancer patients

Investigating the effectiveness of treatment based on acceptance and commitment on tolerance of failure and fear of disease worsening in gastrointestinal cancer patients with stoma in Zahedan

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231120060120N3
Enrollment
40
Registered
2024-07-20
Start date
2024-07-22
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer. Malignant neoplasm of colon

Interventions

Intervention 1: Intervention group: The receiving group of the Treatment Program based on Acceptance and Commitment. Intervention 2: Control group: The group receiving routine care and training in the

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: The patient is suffering from gastrointestinal cancers and will receive stoma treatment He has not participated in stoma care training courses A member of the patient's family should not be part of the treatment staff The patient is not from the treatment staff he patient is not supported by the country's stoma association At least one month has passed since his ostomy surgery Do not have speech or hearing and vision impairment Also, in addition to other patients with temporary and permanent stoma (for any reason), patients with stoma due to grade 1 and 2 cancer will also be included in the study

Exclusion criteria

Exclusion criteria: Aggravation of the disease that leads to hospitalization of the patient Unwillingness to participate or continue to participate in the research

Design outcomes

Primary

MeasureTime frame
Tolerance of Failure. Timepoint: Measurement at the beginning of the study and 3 months after the start of the intervention. Method of measurement: Harrington Failure Tolerance Questionnaire.;Fear of Disease progression. Timepoint: Measurement at the beginning of the study and 3 months after the start of the intervention. Method of measurement: Fear of Disease progression Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahla Dahmardeh

Zahedan University of Medical Sciences

haniedahmardeh@gmail.com+98 54 3348 6610

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026